HER-2 positive - Globe Thesis

Keyword [HER-2 positive] Result: 21 - 40 \| Page: 2 of 3
21.	Cardiotoxic Analysis Of Trastuzumab Treatment In Her-2 Positive Breast Cancer Patients
22.	Molecular Mechanism Of Delphinidin Inducing Cell Cycle Arrest And Apoptosis In HER-2 Positive Breast Cancer Cells
23.	An Observational Study Of Immune Function Status In Patients With HER-2 Positive Early Breast Cancer Treated With Chemotherapy Combined With Trastuzumab
24.	The Cardiotoxicity Risks Of Anthracycline And Trastuzumab In HER-2 Positive Breast Cancer Patients
25.	Application Of Magnetic Resonance Nanoparticles In HER-2 Positive Breast Cancer
26.	The Clinical Observation Of Trastuzumab In The Real World For The Treatment Of Her-2 Positive Breast Cancer
27.	Variation And Analysis Of Gene Copy Number In Her-2 Positive Breast Cancer
28.	Expression Of P95HER2 And Its Clinical Value In HER-2 Positive Breast Cancer Patients
29.	Clinical Study Of Neoadjuvant Chemotherapy With Trastuzumab For Breast Cancer With POSITIVE HER-2
30.	Preliminary Study On Prediction Model Of Gastric Cancer Genomic Data And HER-2 Positive Gastric Cancer Patients Treated With Trastuzumab
31.	Observational Study Of Pyrotinib In The Treatment Of Her-2 Positive Advanced Breast Cancer
32.	A Study On The Correlation Between The Pathological Features And Treatment And Prognosis Of HER-2 Positive Breast Cancer
33.	An Analytical Study On The Cardiotoxicity Of Anthracycline And Trastuzumab In The Treatment Of Her-2 Positive Breast Cancer
34.	Biochanin A and manganese modulate oncogenic signaling and antioxidant function in HER-2-positive breast cancer cells
35.	Multiparametric MRI-based Radiomics Model For Predicting HER-2 2+status Of Breast Cancer And HER-2 Positive Breast Cancer Under Different Status Of HR
36.	Comparison Of Outcoms Between HER2-positive De Novo Stage ? And Relapsed Breast Cancer
37.	Characteristics And Clinical Significance Of Microenvironmental Immune Cells In HER-2 Positive Gastric Cancer
38.	Study On Cardiotoxicity Of Trastuzumab In Patients With HER-2 Positive Breast Cancer
39.	The Effect Of Trastuzumab On The Survival Of T1 HER-2 Positive Early Breast Cancer Patients
40.	Efficacy And Influencing Factors Of Pertuzumab Combined With Trastuzumab In The Neoadjuvant Therapy Of HERT-2 Positive Breast Cancer
<<First <Prev Next> Last>> Jump to